Antipodean Advisors LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.

Quarter-by-quarter ownership
Antipodean Advisors LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q2 2023$2,258,250
-6.9%
75,0000.0%16.02%
+6.7%
Q1 2023$2,426,250
+746.6%
75,000
+650.0%
15.01%
+1468.5%
Q4 2022$286,600
+18.9%
10,0000.0%0.96%
+55.1%
Q3 2022$241,000
-85.3%
10,000
-83.3%
0.62%
-76.9%
Q2 2022$1,643,00060,0002.68%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders